A Phase III, Open-Label Extension Trial of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia [EXTENSION OF 700239254]
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Sponsors AMAG Pharmaceuticals
- 23 Apr 2014 The trial has been terminated as per Clinical Trials Registry - India record and M.D. Anderson Cancer Center record.
- 23 Apr 2014 New source identified and integrated, M.D. Anderson Cancer Center record (2010-0436).
- 23 Apr 2014 New source identified and integrated, Clinical Trials Registry - India (CTRI2010-091-001462).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History